Collectively, our data identify aberrant histone PTMs in splenic JMML HSPCs from patients carrying PTPN11 gain-of-function mutations and implicate the activity of PTM-modifying enzymes as responsible for the observed changes. The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.